ong term observational study on efficiency of a TNF-alpha blocker therapy on nail psoriasis in patients with moderate to severe plaque psoriasis or psoriatic arthritis
- Conditions
- L40L40.5PsoriasisArthropathic psoriasis
- Registration Number
- DRKS00016894
- Lead Sponsor
- Abbott GmbH & Co. KG
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 755
Inclusion Criteria
moderate to severe psoriasis (with PASI, BSA or DLQI > 10)
Exclusion Criteria
Any other skin diseases that could interfere with the evaluation of psoriasis severity or other forms of psoriasis than plaque-type, onychomycosis, latent or active tuberculosis, hepatitis B and C, HIV infection as well as inability to understand the questionnaires and adhere to the trial procedures
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method